Neutrophil elastase and fetal fibronectin levels as predictors of single-birth prematurity

Ai,Fang; Li,Gui‑Qing; Jiang,Jiang; Dong,Xu‑Dong

doi:10.3892/etm.2015.2508

Neutrophil elastase and fetal fibronectin levels as predictors of single-birth prematurity

Authors:
- Fang Ai
- Gui‑Qing Li
- Jiang Jiang
- Xu‑Dong Dong
View Affiliations

Affiliations: Department of Obstetrics, The First People's Hospital of Yunnan, Kunming, Yunnan 650032, P.R. China
Published online on: May 21, 2015 https://doi.org/10.3892/etm.2015.2508
Pages: 665-670

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the predictive values (PVs) of neutrophil elastase (NE) and fetal fibronectin (fFN) in cervical secretions for single‑birth premature delivery. Samples of cervical secretions were obtained from 144 women with high‑risk singleton pregnancies at 20‑34 weeks' gestation and premature Creasy scores of >12 points for NE and fFN level testing, and the PVs of the two indicators for premature birth (PB) were retrospectively analyzed. NE and fFN had high negative PVs (NPVs) for PB; the NPV of NE and fFN for delivery 7 days after detection was significantly higher than the positive PV (P<0.01). In addition, the sensitivity of the combined use of NE and fFN levels for PB prediction was high if both were present, and the PB rate of the double‑positive group was higher than that of the single‑positive group (P<0.01). Clinical intervention could turn the NE and fFN values negative in certain cases; in these cases, the PB rate was significantly lower than that in the sustained‑positive group. In conclusion, NE and fFN in cervical secretions could be used as objective predictors of premature delivery, and their combined application could improve the prediction sensitivity. Effective clinical intervention could then reduce the incidence of PB.

View Figures

View References

1	Iams JD, Goldenberg RL, Mercer BM, et al National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: The preterm prediction study: Can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol. 184:652–655. 2001. View Article : Google Scholar : PubMed/NCBI
2	Russo A, McCready M, Torres L, et al: Reducing hypothermia in preterm infants following delivery. Pediatrics. 133:e1055–e1062. 2014. View Article : Google Scholar : PubMed/NCBI
3	Pappas A, Kendrick DE, Shankaran S, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 168:137–147. 2014. View Article : Google Scholar : PubMed/NCBI
4	Borg F, Gravino G, Schembri-Wismayer P and Calleja-Agius J: Prediction of preterm birth. Minerva Ginecol. 65:345–360. 2013.PubMed/NCBI
5	Bolt LA, Morrison K and Shennan AH: The use of fetal fibronectin testing and cervical length measurement in the prediction of delivery of triplet pregnancies. Eur J Obstet Gynecol Reprod Biol. 164:236–237. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bastek JA, Hirshberg A, Chandrasekaran S, et al: Biomarkers and cervical length to predict spontaneous preterm birth in asymptomatic high-risk women. Obstet Gynecol. 122:283–289. 2013. View Article : Google Scholar : PubMed/NCBI
7	Zhang S, Fu S, Liu Y, et al: Predictive value of fetal fibronectin on the embryonic loss of patients with recurrent spontaneous abortion in early pregnancy. Clin Exp Obstet Gynecol. 41:380–383. 2014.PubMed/NCBI
8	Foster C and Shennan AH: Fetal fibronectin as a biomarker of preterm labor: A review of the literature and advances in its clinical use. Biomark Med. 8:471–484. 2014. View Article : Google Scholar : PubMed/NCBI
9	Ikeda S, Kihita K, Yokoi A, Tamakoshi K, Miyazaki K and Furuhashi M: The levels of the neutrophil elastase in the amniotic fluid of pregnant women whose infants develop bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 28:479–483. 2015. View Article : Google Scholar : PubMed/NCBI
10	Le Gars M, Descamps D, Roussel D, et al: Neutophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function n vitro and n vivo. Am J Respir Crit Care Med. 187:170–179. 2013. View Article : Google Scholar : PubMed/NCBI
11	Honest H, Bachmann LM, Sundaram R, Gupta JK, Kleijnen J and Khan KS: The accuracy of risk scores in predicting preterm birth - a systematic review. J Obstet Gynaecol. 24:343–359. 2004. View Article : Google Scholar : PubMed/NCBI
12	Barrios YV, Sanchez SE, Qiu C, Gelaye B and Williams MA: Risk of spontaneous preterm birth in relation to maternal experience of serious life events during pregnancy. Int J Womens Health. 6:249–257. 2014. View Article : Google Scholar : PubMed/NCBI
13	van Vliet EO, Boormans EM, de Lange TS, Mol BW and Oudijk MA: Preterm labor: Current pharmacotherapy options for tocolysis. Expert Opin Pharmacother. 15:787–797. 2014. View Article : Google Scholar : PubMed/NCBI
14	Klein LL and Gibbs RS: Infection and preterm birth. Obstet Gynecol Clin North Am. 32:397–410. 2005. View Article : Google Scholar : PubMed/NCBI
15	Newton ER: Preterm labor, preterm premature rupture of membranes and chorioamnionitis. Clin Perinatol. 32:571–600. 2005. View Article : Google Scholar : PubMed/NCBI
16	Park CW, Yoon BH, Kim SM, Park JS and Jun JK: The frequency and clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts. Obstet Gynecol Sci. 56:167–175. 2013. View Article : Google Scholar : PubMed/NCBI
17	Fjaertoft G, Håkansson L, Foucard T, Ewald U and Venge P: CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants. Acta Paediatr. 94:295–302. 2005. View Article : Google Scholar : PubMed/NCBI
18	Rossel Goffeng A, Holst E, Milsom I, Lindstedt G, Lundberg PA and Andersch B: Fetal fibronectin and microorganisms in vaginal fluid of healthy pregnant women. Acta Obstet Gynecol Scand. 75:520–525. 1996. View Article : Google Scholar : PubMed/NCBI
19	Yoon BH, Romero R, Moon JB, Oh SY, Han SY, Kim JC and Shim SS: The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin. Am J Obstet Gynecol. 185:1137–1142. 2001. View Article : Google Scholar : PubMed/NCBI
20	Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L and Garite TJ: Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 325:669–674. 1991. View Article : Google Scholar : PubMed/NCBI
21	Conde-Agudelo A and Romero R: Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: A systematic review and meta-analysis. J Matern Fetal Neonatal Med. 23:1365–1376. 2010. View Article : Google Scholar : PubMed/NCBI
22	Abdelazim IA: Fetal fibronectin [Quick Check fFN test(®)] for detection of premature rupture of fetal membranes. Arch Gynecol Obstet. 287:205–210. 2013. View Article : Google Scholar : PubMed/NCBI
23	Peláez LM, Fox NS and Chasen ST: Negative fetal fibronectin: Who is still treating for threatened preterm labor and does it help? J Perinat Med. 36:202–205. 2008. View Article : Google Scholar : PubMed/NCBI
24	Roman AS, Rebarber A, Lipkind H, Mulholland J, Minior V and Roshan D: Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction. Am J Obstet Gynecol. 190:142–146. 2004. View Article : Google Scholar : PubMed/NCBI
25	Silver BJ, Guy RJ, Kaldor JM, Jamil MS and Rumbold AR: Trichomonas vaginalis as a cause of perinatal morbidity: A systematic review and meta-analysis. Sex Transm Dis. 41:369–376. 2014. View Article : Google Scholar : PubMed/NCBI
26	Faye-Petersen OM: The placenta in preterm birth. J Clin Pathol. 61:1261–1275. 2008. View Article : Google Scholar : PubMed/NCBI
27	Czerwińska ME, Kiss AK and Naruszewicz M: Inhibition of human neutrophils NEP activity, CD11b/CD18 expression and elastase release by 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde, oleacein. Food Chem. 153:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
28	Krupa FG, Faltin D, Cecatti JG, Surita FG and Souza JP: Predictors of preterm birth. Int J Gynaecol Obstet. 94:5–11. 2006. View Article : Google Scholar : PubMed/NCBI
29	Czajka R, Kwiatkowski S, Chlubek D, Dołegowska B, Torbé A and Rzepka R: The assessment of neutrophil elastase measurements usefulness in pregnant women with premature rupture of fetal membranes and chorioamnionitis suspicion. Ginekol Pol. 80:19–24. 2009.(In Polish). PubMed/NCBI
30	Kidokoro K, Furuhashi M, Kuno N and Ishikawa K: Amniotic fluid neutrophil elastase and lactate dehydrogenase: Association with histologic chorioamnionitis. Acta Obstet Gynecol Scand. 85:669–674. 2006. View Article : Google Scholar : PubMed/NCBI
31	Nakai A, Taniuchi Y, Miyake H, Nakai M, Yokota A and Takeshita T: Increased level of granulocyte elastase in cervical secretion is an independent predictive factor for preterm delivery. Gynecol Obstet Invest. 60:87–91. 2005. View Article : Google Scholar : PubMed/NCBI
32	Morken NH, Källen K and Jacobsson B: Predicting risk of spontaneous preterm delivery in women with a singleton pregnancy. Paediatr Perinat Epidemiol. 28:11–22. 2014. View Article : Google Scholar : PubMed/NCBI
33	Sananes N, Meyer N, Gaudineau A, et al: Prediction of spontaneous preterm delivery in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol. 171:18–22. 2013. View Article : Google Scholar : PubMed/NCBI